Replies to post #3548 on Repros Therapeutics Inc (RPRX)

[iwfal]

I think it's readily a trade-of with Costs.

Of course. But 95% of small biotech do what ends up being the penny wise, pound foolish approach of being overly optimistic about the TRUE efficacy and thus underpowering their trials.

The question is whether Repros is doing this.